Screener
GoodRx Holdings, Inc. GDRX Q1 2026 earnings
Reported May 6, 2026 · After market close
Revenue$194.0MBeat by $8.6M
EPS$0.07In line
Revenue estimate$185.4M
EPS estimate$0.07
Next report
Nov 3, 2026 (In 3 weeks)Revenue estimate$201.9M
EPS estimate$0.08
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did GoodRx Holdings, Inc. report Q1 2026 earnings?
- GoodRx Holdings, Inc. (GDRX) reported Q1 2026 earnings on May 6, 2026 after market close.
- What were GoodRx Holdings, Inc.'s Q1 2026 revenue and EPS?
- GoodRx Holdings, Inc. reported revenue of $194.0M and eps of $0.07 for Q1 2026.
- Did GoodRx Holdings, Inc. beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $185.4M by $8.6M. EPS beat the consensus estimate of $0.07 by $0.00.
- How did GoodRx Holdings, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 4.4% from $203.0M a year earlier and eps declined 22.2% from $0.09.
- Where can I find GoodRx Holdings, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001809519-26-000110) and the 10-Q periodic report (0001809519-26-000111) directly on SEC EDGAR. The filing index links above go to sec.gov.
